What does Apotheek Londerzeel do?

Apotheek Londerzeel is a pharmacy in Londerzeel. Public Limited, started on 28 March 1983, 2 establishments.

What is the address of Apotheek Londerzeel?

The registered office of Apotheek Londerzeel is located at Dorpsstraat 4, 1840 Londerzeel.

Is Apotheek Londerzeel still active?

Yes. According to the CBE (29 October 2026) Apotheek Londerzeel is active, legal situation “Normale toestand”, started on 28 March 1983.

Is Apotheek Londerzeel registered on Peppol?

Yes, Apotheek Londerzeel is registered on the Peppol network with ID 0208:0424004321.

What is the enterprise number of Apotheek Londerzeel?

The enterprise number of Apotheek Londerzeel is BE0424004321.

When was Apotheek Londerzeel founded?

Apotheek Londerzeel was founded on 28 March 1983.

Who are the directors of Apotheek Londerzeel?

According to the 2025 annual accounts, the directors of Apotheek Londerzeel are: Pharma4Future.

Is Apotheek Londerzeel a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 March 1983; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Apotheek Londerzeel make in 2025?

Apotheek Londerzeel posted a profit after taxes of € 110,455 in financial year 2025.

What is the revenue of Apotheek Londerzeel?

As a small company, Apotheek Londerzeel is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 492,075.

How much does an employee at Apotheek Londerzeel earn?

The average wage cost per full-time employee at Apotheek Londerzeel was € 72,000 in 2025: staff costs of € 331,280 for 4.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Londerzeel have?

According to the 2025 annual accounts, Apotheek Londerzeel has 4.6 full-time equivalents (FTE).

Does Apotheek Londerzeel have a website?

Yes, Apotheek Londerzeel has a website at apotheeklonderzeel.be.

Apotheek Londerzeel (Public Limited) - Londerzeel

Dossier Apotheek Londerzeel, printed on 29 October 2026 from databakkes.be/en/0424004321/apotheek-londerzeel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Londerzeel from Londerzeel, company number BE0424004321, closed financial year 2025 with a result of € 110,455 after tax. For that financial year Apotheek Londerzeel recorded a gross margin of € 492,075 and equity of € 749,320. Compared with financial year 2024, the result moved from € 98,776 to € 110,455. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 749,320

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 110,455

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 305,311

▲ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 110,000 paid out

100 % of the profit went to the shareholders, mostly to Pharma4Future (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

4.6

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 331,280

▲ 9% vs 2024

€ 72,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 658

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 101,161

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 38,022

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 330,356 Gross margin 2022: € 330,356 First fiscal year in the series	€ 369,927 Gross margin 2023: € 369,927 ▲ 12% vs 2022 (€ 330,356) Favourable step	€ 453,430 Gross margin 2024: € 453,430 ▲ 23% vs 2023 (€ 369,927) Favourable step	€ 492,075 Gross margin 2025: € 492,075 ▲ 9% vs 2024 (€ 453,430) Favourable step	▲ 9%
Profit after taxes	€ -7,231 Profit after taxes 2022: € -7,231 First fiscal year in the series	€ 28,505 Profit after taxes 2023: € 28,505 ▲ € 35,736 vs 2022 (€ -7,231) Favourable step	€ 98,776 Profit after taxes 2024: € 98,776 ▲ 247% vs 2023 (€ 28,505) Favourable step	€ 110,455 Profit after taxes 2025: € 110,455 ▲ 12% vs 2024 (€ 98,776) Favourable step	▲ 12%
Equity	€ 639,912 Equity 2022: € 639,912 First fiscal year in the series	€ 640,417 Equity 2023: € 640,417 Unchanged (€ 639,912) Favourable step	€ 748,865 Equity 2024: € 748,865 ▲ 17% vs 2023 (€ 640,417) Favourable step	€ 749,320 Equity 2025: € 749,320 Unchanged (€ 748,865) Favourable step
Total debts	€ 360,959 Total debts 2022: € 360,959 First fiscal year in the series	€ 302,660 Total debts 2023: € 302,660 ▼ 16% vs 2022 (€ 360,959) Favourable step	€ 245,685 Total debts 2024: € 245,685 ▼ 19% vs 2023 (€ 302,660) Favourable step	€ 249,983 Total debts 2025: € 249,983 ▲ 2% vs 2024 (€ 245,685) Unfavourable step	▲ 2%
Cash	€ 216,499 Cash 2022: € 216,499 First fiscal year in the series	€ 170,997 Cash 2023: € 170,997 ▼ 21% vs 2022 (€ 216,499) Unfavourable step	€ 185,247 Cash 2024: € 185,247 ▲ 8% vs 2023 (€ 170,997) Favourable step	€ 305,311 Cash 2025: € 305,311 ▲ 65% vs 2024 (€ 185,247) Favourable step	▲ 65%
Retained profit	€ 574,912 Retained profit 2022: € 574,912 First fiscal year in the series	€ 575,417 Retained profit 2023: € 575,417 Unchanged (€ 574,912) Favourable step	€ 665,265 Retained profit 2024: € 665,265 ▲ 16% vs 2023 (€ 575,417) Favourable step	€ 665,720 Retained profit 2025: € 665,720 Unchanged (€ 665,265) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 28,000 Dividend 2023: € 28,000 Unchanged (€ 0) Unchanged	€ 100,250 Dividend 2024: € 100,250 ▲ 258% vs 2023 (€ 28,000) Unchanged	€ 110,000 Dividend 2025: € 110,000 ▲ 10% vs 2024 (€ 100,250) Unchanged	▲ 10%
Bank debt	€ 73,320 Bank debt 2022: € 73,320 First fiscal year in the series	€ 45,825 Bank debt 2023: € 45,825 ▼ 37% vs 2022 (€ 73,320) Favourable step	€ 9,165 Bank debt 2024: € 9,165 ▼ 80% vs 2023 (€ 45,825) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 9,165) Favourable step	▼ 100%
Balance sheet total	€ 1,000,871 Balance sheet total 2022: € 1,000,871 First fiscal year in the series	€ 943,077 Balance sheet total 2023: € 943,077 ▼ 6% vs 2022 (€ 1,000,871) Unchanged	€ 994,550 Balance sheet total 2024: € 994,550 ▲ 5% vs 2023 (€ 943,077) Unchanged	€ 999,303 Balance sheet total 2025: € 999,303 Unchanged (€ 994,550) Unchanged
Employees (FTE)	3.6 Employees (FTE) 2022: 3.6 First fiscal year in the series	3.9 Employees (FTE) 2023: 3.9 ▲ 0.3 vs 2022 (3.6) Unchanged	4.7 Employees (FTE) 2024: 4.7 ▲ 0.8 vs 2023 (3.9) Unchanged	4.6 Employees (FTE) 2025: 4.6 ▼ 0.1 vs 2024 (4.7) Unchanged	▼ 0.1

Key figures of Apotheek Londerzeel, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Londerzeel?

What happened at Apotheek Londerzeel in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Pharma4Future stepped down as director. NBB
Jul 2, 2026 New annual accounts for financial year 2025: profit of € 110,455 (▲ 12% vs 2024). Source: NBB ↗
Oct 1, 2022 New establishment in Londerzeel. KBO
2022 Pharma4Future became a director. NBB
Apr 1, 1983 New establishment in Londerzeel. KBO
Mar 28, 1983 Start of the company according to the CBE. KBO

In short

From € 7,231 loss in 2022 to € 110,455 profit in 2025.

Paid € 3,865 in corporate taxes since 2022.

Best year ever: 2025, with € 110,455 profit.

On average € 107,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Pharma4Future 100%

The stake of Pharma4Future comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Londerzeel

The shares are held by Pharma4Future (100%).

Directors

According to the 2025 annual accounts

Pharma4Future

Director · represented by Sven Lenaerts

Also active at: MEEUS-DENEVE, APOTHEEK BREENDONKFARMA

since 2022 · until 2028

Shareholders

Pharma4Future

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 4

1840 Londerzeel

2.337.924.583

Mechelsestraat 19

1840 Londerzeel

Active since 1 October 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeklonderzeel.be

About

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Website info

HTTPS Ja

Languages NL

Features

Webshop Client portal Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0424.004.321

VAT number

BE 0424.004.321

Registered office

Dorpsstraat 4, 1840 Londerzeel

Names & denominations

Apotheek Londerzeel

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

28 March 1983

Peppol

Active · Active since 13 Aug 2025

Contact

apotheeklonderzeel.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Londerzeel

Financials

What happened to Apotheek Londerzeel?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions